Skip to main content

1243 results

Publication

Covid-19: Vetoquinol donates masks to neighboring healthcare facilities

Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions.
News

Covid-19: Vetoquinol donates masks to neighboring healthcare facilities.

Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions. Matthieu Frechin, CEO of...
Publication

Monthly information regarding the total number of voting rights and shares making of the share capital - February 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »
Publication

Programme de rachat - February 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres
Basic page

Vetoquinol's company values

Vetoquinol's company values can be summed up in three points: Trust - We recognise the commitment, reliability, integrity, and skills of every individual. Dare - We adopt an entrepreneurial mindset. We take initiative. We innovate, not fearing failure. And we learn from our experiences. Collaborate...
News

Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European economic area and the UK

February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health. This acquisition will be financed through a combination of available cash and committed financing from...
Publication

Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European economic area and the UK

February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health.
Publication

Programme de rachat - January 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres
Publication

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »
News

2019 sales: €396.0 million (Up 7.6%)

The Vetoquinol Group posted 2019 sales of €396.0 million, up 7.6% as reported and up 6.1% at constant exchange rates. Sales of Essentials products, the driving force behind Vetoquinol’s strategy, totaled €190.6 million, up 5.1% at constant exchange rates. Essentials products accounted for 48.1% of...